Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors Metodi Metodiev, University of Essex, speaking at Diagnostics and Biomarkers 2015.
New Metabolomics Biomarker for Heart Failure Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry Daniel Chelsky, Caprion Proteomics Inc, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Contributions of Mass Spectrometry in the Diagnosis and Management of Hypothalamic–pituitary–adrenal Axis Disorders Gregori Casals, Hospital Clínic Barcelona, speaking at Clinical Applications of Mass Spectrometry.
History and Development of High Resolution Mass Spectrometry for Infectious Disease Diagnostics Haroun Shah, Public Health England, speaking at Clinical Applications of Mass Spectrometry.
Recent Foodomic Developments to Investigate the Bioactivity of Dietary Ingredients Alejandro Cifuentes, Institute of Food Science Research, speaking at Food Analysis Congress.
Diagnosis of Disorders Affecting Steroid Synthesis and Metabolism by Mass Spectrometry Josep Marcos del Aguila, IMIM, speaking at Clinical Applications of Mass Spectrometry 2014.